Sinopharm has a total of 2259 patents globally, out of which 1453 have been granted. Of these 2259 patents, more than 53% patents are active. China is where Sinopharm has filed the maximum number of patents, followed by United States of America and Europe. Parallelly, China seems to be the main focused R&D center and is also the origin country of Sinopharm.
China National Pharmaceutical Group Corporation, commonly referred to as Sinopharm was founded in the year 1998 by the Republic of China. Company is doing business in pharmaceutical. As of December 2021, Sinopharm has a market cap of $6.77 Billion.
Do read about some of the most popular patents of Sinopharm which have been covered by us in this article and also you can find Sinopharm’s patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Sinopharm’s patent portfolio.
How many patents does Sinopharm have?
Sinopharm has a total of 2259 patents globally. These patents belong to 1807 unique patent families. Out of 2259 patents, 1200 patents are active.
How many Sinopharm patents are Alive/Dead?
How Many Patents did Sinopharm File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
|Year of Patents Filing or Grant||Sinopharm Applications Filed||Sinopharm Patents Granted|
How Many Patents did Sinopharm File in Different Countries?
Countries in which Sinopharm Filed Patents
|United States Of America||51|
|Hong Kong (S.A.R.)||16|
|Republic of Moldova||2|
|Gulf Cooperation Council||1|
Where are Research Centers of Sinopharm Patents Located?
10 Best Sinopharm Patents
WO2005084711A1 is the most popular patent in the Sinopharm portfolio. It has received 210 citations so far from companies like Amgen, Intrinsic Lifesciences and F. Hoffmann-La Roche Ag.
Below is the list of 10 most cited patents of Sinopharm:
|Publication Number||Citation Count|
In recent years, China’s smart manufacturing industry has achieved some strides. Smart manufacturing has a significant impact on the pharmaceutical business, resulting in the three development trends shown below. The first is to improve the pharmaceutical industry’s intelligence and information levels, as well as to popularise manufacturing execution systems in production processes, allowing for whole-process monitoring and management of drug quality. The second is to improve the applications of computer-aided drug design, 3D printing, and virtual reality during research and development by developing new production procedures (R&D). The third step is to increase industry concentration, alter the pharmaceutical industry’s market structure to one based on industrial integration, and promote the pharmaceutical industry to the global market.
The COVID-19 vaccine from Sinopharm is the first of the new vaccinations to include a vaccine vial monitor, or VVM, which tells health workers whether the vaccine has been stored properly and has not been harmed by extreme heat.
EXCLUSIVE INSIGHTS COMING SOON!
What are Sinopharm key innovation segments?
What Technologies are Covered by Sinopharm?
The chart below distributes patents filed by Sinopharm in different countries on the basis of the technology protected in patents. It also represents the markets where Sinopharm thinks it’s important to protect particular technology inventions.
R&D Focus: How Sinopharm search focus changed over the years?
EXCLUSIVE INSIGHTS COMING SOON!
Interested in knowing about the areas of innovation that are being protected by Sinopharm?